Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akinobu Yoshimura

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|November 27, 2012
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusionKazuhiro Kitamura, Kaoru Kubota, Masahiro Ando, et al.
Thoracic Cancer|January 22, 2021
Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancerRyota Kikuchi, Hiroyuki Takoi, Takao Tsuji, et al.
Thoracic Cancer|May 3, 2021
Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancerRyota Kikuchi, Hiroyuki Takoi, Takao Tsuji, et al.
BMC Cancer|April 18, 2015
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutationRintaro Noro, Masahiro Seike, Fenfei Zou, et al.
Japanese Journal of Clinical Oncology|September 19, 2024
A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancersSusumu Takeuchi, Akinobu Yoshimura, Atsushi Sofuni, et al.
Genes, Chromosomes & Cancer|April 16, 2003
Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancerAkinobu Yoshimura, Akihiko Gemma, Yoko Hosoya, et al.
Experimental and Therapeutic Medicine|November 9, 2012
Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panelMitsunori Hino, Kuniko Matsuda, Akihiko Miyanaga, et al.
BMJ Open|November 22, 2023
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort studyTaiki Hirata, Takashi Kawaguchi, Kanako Azuma, et al.
Anticancer Research|March 14, 2013
Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancerRintaro Noro, Akinobu Yoshimura, Kazuo Yamamoto, et al.
BMC Cancer|July 4, 2006
Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity databaseAkihiko Gemma, Cai Li, Yuka Sugiyama, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|November 27, 2012
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusionKazuhiro Kitamura, Kaoru Kubota, Masahiro Ando, et al.
Thoracic Cancer|January 22, 2021
Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancerRyota Kikuchi, Hiroyuki Takoi, Takao Tsuji, et al.
Thoracic Cancer|May 3, 2021
Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancerRyota Kikuchi, Hiroyuki Takoi, Takao Tsuji, et al.
BMC Cancer|April 18, 2015
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutationRintaro Noro, Masahiro Seike, Fenfei Zou, et al.
Japanese Journal of Clinical Oncology|September 19, 2024
A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancersSusumu Takeuchi, Akinobu Yoshimura, Atsushi Sofuni, et al.
Genes, Chromosomes & Cancer|April 16, 2003
Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancerAkinobu Yoshimura, Akihiko Gemma, Yoko Hosoya, et al.
Experimental and Therapeutic Medicine|November 9, 2012
Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panelMitsunori Hino, Kuniko Matsuda, Akihiko Miyanaga, et al.
BMJ Open|November 22, 2023
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort studyTaiki Hirata, Takashi Kawaguchi, Kanako Azuma, et al.
Anticancer Research|March 14, 2013
Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancerRintaro Noro, Akinobu Yoshimura, Kazuo Yamamoto, et al.
BMC Cancer|July 4, 2006
Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity databaseAkihiko Gemma, Cai Li, Yuka Sugiyama, et al.
Pageof 6